Which medications used in paediatric practice have demonstrated natural health product-drug interactions? Part A: Evidence-based answer and summary

Paediatrics and Child Health

Volumn 11, Issue 10, 2006, Pages 671-672

  Johnston, Brad ^a   Vohra, Sunita ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; CYCLOSPORIN A; DIGOXIN; ECHINACEA EXTRACT; ETONOGESTREL; FEXOFENADINE; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; INDINAVIR; MIDAZOLAM; NATURAL PRODUCT; OMEPRAZOLE; SAQUINAVIR; SIMVASTATIN; TACROLIMUS; WARFARIN;

ALLERGIC RHINITIS; ALTERNATIVE MEDICINE; AREA UNDER THE CURVE; CANADA; CHILD HEALTH CARE; CHRONIC DISEASE; DEPRESSION; DRUG ABSORPTION; DRUG ANTAGONISM; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG METABOLISM; DRUG POTENTIATION; DRUG USE; EVIDENCE BASED MEDICINE; HEALTH SURVEY; HUMAN; MEDICAL PRACTICE; SHORT SURVEY;

EID: 33846411816     PISSN: 12057088     EISSN: None     Source Type: Journal    
DOI: 10.1093/pch/11.10.671     Document Type: Short Survey

References (31)

1. Goldman RD, Vohra S. Complementary and alternative medicine use by children visiting a pediatric emergency department. Abstracts from the First Annual Complementary and Alternative Health Care and Paediatrics Forum, December 2 to 3, 2004. Can J Clin Pharmacol 2004;11:e254-56. (Abst 5)
2. Lanski SL, Greenwald M, Perkins A, Simon HK. Herbal therapy use in a pediatric emergency department population: Expect the unexpected. Pediatrics 2003;111:981-5.
3. Madsen H, Andersen S, Nielsen RG, Dolmer BS, Host A, Damkier A. Use of complementary/alternative medicine among paediatric patients. Eur J Pediatr 2003;162:334-41.
4. Trigazis L, Tennankore D, Vohra S, Katzman DK. The use of herbal remedies by adolescents with eating disorders. Int J Eat Disord 2004;35:223-8.
5. Simpson N, Roman K. Complementary medicine use in children: Extent and reasons. A population-based study. Br J Gen Pract 2001;51:914-6.
6. Neuhouser ML, Patterson RE, Schwartz SM, Hedderson MM, Bowen DJ, Standish LJ. Use of alternative medicine by children with cancer in Washington state. Prev Med 2001;33:347-54.
7. Chan E, Rappaport LA, Kemper KJ. Complementary and alternative therapies in childhood attention and hyperactivity problems. J Dev Behav Pediatr 2003;24:4-8.
8. Breuner CC, Barry PJ, Kemper KJ. Alternative medicine use by homeless youth. Arch Pediatr Adolesc Med 1998;152:1071-5.
9. Mills E, Wu P, Johnston BC, Gallicano K, Clarke M, Guyatt G. Natural health product-drug interactions: A systematic review of clinical trials. Ther Drug Monit 2005;27:549-57.
10. Johnston BC, Wu P, Mills EJ. Herb-drug interaction implications for pediatric clinical practice: An overview of pharmacokinetic trials. Arch Pediatr Adolesc Med 2005;159:692.
11. Taketomo CK, Hodding JH, Kraus DM, eds. Pediatric Dosage Handbook, 10th edn. Hudson: Lexi-Comp Inc, 2003.
12. Gunn VL, Nechyba C. The Harriet Lane Handbook: A Manual for Pediatric House Officers, 16th edn. Philadelphia: Mosby Inc, 2002.
13. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: A randomized, controlled trial. Ann Intern Med 2004;141:23-7.
14. Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004;75:89-100.
15. Piscitelli SC, Burstein AH, Welden N, Gallicano KD, Falloon J. The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 2002;34:234-8.
16. Markowitz JS, Donovan JL, Lindsay DeVane C, Sipkes L, Chavin KD. Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers. J Clin Psychopharmacol 2003;23:576-81.
17. Markowitz JS, DeVane CL, Boulton DW, Carson SW, Nahas Z, Risch SC. Effect of St John's wort (Hypericum perforatum) on cytochrome P-450 2D6 and 3A4 activity in healthy volunteers. Life Sci 2000;66:PL133-9.
18. Markowitz JS, Donovan JL, DeVane CL, et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 2003;290:1500-4.
19. Johne A, Schmider J, Brockmoller J, et al. Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St John's wort (Hypericum perforatum). J Clin Psychopharmacol 2002;22:46-54.
20. Bauer S, Stormer E, Johne A, et al. Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients. Br J Clin Pharmacol 2003;55:203-11.
21. Johne A, Brockmoller J, Bauer S, Maurer A, Langheinrich M, Roots I. Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999;66:338-45.
22. Mueller SC, Uehleke B, Woehling H, et al. Effect of St John's wort dose and preparations on the pharmacokinetics of digoxin. Clin Pharmacol Ther 2004;75:546-57.
23. Dresser OK, Schwarz UI, Wilkinson GR, Kim RB. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clin Pharmacol Ther 2003;73:41-50.
24. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000;355:547-8.
25. Wang LS, Zhou G, Zhu B, et al. St John's wort induces both cytochrome P450 3A4-catalyzed sulfoxidation and 2C19-dependent hydroxylation of omeprazole. Clin Pharmacol Ther 2004;75:191-7.
26. Pfrunder A, Schiesser M, Gerber S, Haschke M, Bitzer J, Drewe J. Interaction of St John's wort with low-dose oral contraceptive therapy: A randomized controlled trial. Br J Clin Pharmacol 2003;56:683-90.
27. Sugimoto K, Ohmori M, Tsuruoka S, et al. Different effects of St John's wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 2001;70:518-24.
28. Mai I, Stormer E, Bauer S, Kruger H, Budde K, Roots I. Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 2003;18:819-22.
29. Hebert MF, Park JM, Chen YL, Akhtar S, Larson AM. Effects of St John's wort (Hypericum perforatum) on tacrolimus pharmacokinetics in healthy volunteers. J Clin Pharmacol 2004;44:89-94.
30. Jiang X, William KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57:592-9.
31. Bailey DG, Dresser GK. Natural products and adverse drug interactions. CMAJ 2004;170:1531-2.